Familial Adenomatous Polyposis Clinical Trial
Official title:
Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
This randomized phase II trial studies curcumin in treating patients with familial adenomatous polyposis. Curcumin may prevent colorectal cancer in patients with a history of rectal polyps or colorectal neoplasia.
Specific Aims:
I. To determine in a randomized, double-blinded, placebo-controlled study the tolerability
and effectiveness of curcumin to regress intestinal adenomas by measuring duodenal and
colorectal/ileal polyp number, and polyp size in familial adenomatous polyposis patients with
intact colons, ileorectal anastomosis surgery, or ileo-anal pullthrough (reservoir) surgery.
II. To measure markers of cell proliferation including colorectal mucosal levels of ornithine
decarboxylase (ODC), polyamines, mucosal deoxyribonucleic acid (DNA) methylation,
proliferative index (Ki67 antiproliferative cell nuclear antibody), apoptosis index, vascular
density, mucosal prostaglandin, leukotriene levels, and activation of the nuclear factor
kappa B (NFKB), and v-akt murine thymoma viral oncogene homolog 1 (Akt) survival pathways.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
Arm I: Patients receive curcumin orally (PO) twice daily (BID) for 12 months.
Arm II: Patients receive placebo PO BID for 12 months.
After completion of study treatment, patients are followed up at 4 months.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05630794 -
Testing ONC201 to Prevent Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02961374 -
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
|
Phase 2 | |
| Completed |
NCT01483144 -
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 | |
| Recruiting |
NCT03471403 -
Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
|
||
| Not yet recruiting |
NCT04531930 -
Colorectal Adenoma Canceration in FAP
|
||
| Recruiting |
NCT04677998 -
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
|
||
| Recruiting |
NCT04678011 -
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
|
||
| Completed |
NCT00927485 -
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
|
N/A | |
| Recruiting |
NCT00253812 -
Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy
|
N/A | |
| Withdrawn |
NCT00248053 -
Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
|
Phase 2 | |
| Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
| Completed |
NCT04674228 -
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
|
||
| Completed |
NCT01656746 -
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
|
N/A | |
| Completed |
NCT00808743 -
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT03847636 -
CryoBalloon Ablation for Treatment of Duodenal Adenomas
|
N/A | |
| Not yet recruiting |
NCT05112822 -
Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)
|
Phase 1 | |
| Recruiting |
NCT02656134 -
Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)
|
N/A | |
| Withdrawn |
NCT01245816 -
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 | |
| Recruiting |
NCT04709445 -
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
|
N/A | |
| Enrolling by invitation |
NCT05402891 -
The CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous Polyposis
|
Phase 2 |